Results 21 to 30 of about 160,524 (198)
Allergic bronchopulmonary aspergillosis
Indian Journal of Medical Research, 2020 Allergic bronchopulmonary aspergillosis (ABPA) is an inflammatory disease caused by immunologic reactions initiated against Aspergillus fumigatus colonizing the airways of patients with asthma and cystic fibrosis. The common manifestations include treatment-resistant asthma, transient and fleeting pulmonary opacities and ...
Agarwal, Ritesh +7 more
openaire +2 more sources
Recurrent hemoptysis in a patient with bronchial asthma
Journal of Advanced Lung Health, 2021 Hemoptysis is not a common symptom in bronchial asthma. We aim to discuss the approach to a patient with uncontrolled asthma with recurrent hemoptysis in this case-based discussion.
Vishnu M Sharma, Baseer Ahmmad Walikar
doaj +1 more source
Pictorial essay: Allergic bronchopulmonary aspergillosis
Indian Journal of Radiology and Imaging, 2011 Allergic bronchopulmonary aspergillosis (ABPA) is the best-known allergic manifestation of Aspergillus-related hypersensitivity pulmonary disorders. Most patients present with poorly controlled asthma, and the diagnosis can be made on the basis of a ...
Ritesh Agarwal +4 more
doaj +1 more source
Criteria for the diagnosis of allergic bronchopulmonary aspergillosis.
, 2013 Criteria for the diagnosis of allergic bronchopulmonary aspergillosis.
Dheeraj Gupta (56317) +6 more
core +1 more source
Allergic bronchopulmonary Aspergillosis in children
TURKISH JOURNAL OF MEDICAL SCIENCES, 2021 Allergic bronchopulmonary aspergillus (ABPA) is a lung disease caused by hypersensitivity from Aspergillus fumigatus. Diagnostic criteria, staging systems and treatment methods for ABPA disease have been reported in studies evaluating populations, the majority of which are adult patients.
Özge ATAY +6 more
openaire +3 more sources
Allergic bronchopulmonary aspergillosis: Indian scenario
Indian Journal of Allergy Asthma and Immunology, 2019 Aspergillus is ubiquitous, occurring in mycelial form and grows at 15-530C and humid conditions. Pulmonary aspergillosis is a clinical spectrum of lung disease caused by the fungus Aspergillus.
Rajendra Prasad +2 more
doaj +1 more source
Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis
, 1995 Invasive pulmonary aspergillosis is a frequent complication in immunocompromised patients. The role of the prolonged use of steroids in predisposing to invasive aspergillosis has been recognized, but exceptionally described in asthmatic patients.
A. Ganassini, CAZZADORI, Angelo Antonio
core +1 more source
Tezepelumab treatment for allergic bronchopulmonary aspergillosis
Respirology Case Reports, 2023 An 82‐year‐old man had been diagnosed with asthma. He experienced repeated exacerbations requiring treatment with a systemic corticosteroid despite being treated with medications including high‐dose fluticasone furoate/umeclidinium/vilanterol ...
Hiroaki Ogata +8 more
doaj +1 more source
European Journal of Haematology, EarlyView.ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley +1 more source
Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis
, 2016 Background Itraconazole (ITZ) is an alternative to steroids in the treatment of allergic bronchopulmonary aspergillosis (ABPA) but therapeutic drug monitoring (TDM) is warranted due to erratic absorption and early relapse.
Agarwal, Kshitij +9 more
core +1 more source